Alzheimer's leans to memory loss then progressive failure of mental and physical functions Early results in a new treatment for one of the most common forms of dementia have been "absolutely ...

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...

The three patients, between the ages of 59 and 77, all had mild Alzheimer’s disease. During the study, they received six ...

DLB is closely related to Alzheimer's and Parkinson's ... benefits of ChEIs for patients with DLB and support updating treatment guidelines," says neurobiologist Maria Eriksdotter.

first session of receive the newly FDA approved Alzheimer's treatment Leqembi while Williford's wife Cynthia Byron-Williford, 59, right, watches at Abington Neurological Associates in Abington ...

A Pennsylvania woman is one of the first patients in the country to receive a new FDA-approved treatment for early symptomatic Alzheimer's disease. Karen Chung, 63, from Chester Springs ...

Furthermore, it has been suggested that many drugs in clinical trials fail to show efficacy as they are tested in patients with advanced forms of dementia. Thus, early diagnosis of neurocognitive ...

On Tuesday, The Ministry of Health, Labour and Welfare Japan approved Eli Lilly And Co’s (NYSE:LLY) Kisunla (donanemab) for adults with early symptomatic Alzheimer’s disease (AD), which ...

(Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease ("Alzheimer’s"), bipolar disorder ("BD ...